IL2 and neoplasm: However, it is interesting to note that IL-2 improved the accumulation of CAR-T cells in vitro [21], even though IL-2-treated CAR-T cells display reduced anti-tumor cytotoxicity. Further experiments are required to determine whether other cytokine conditions can outperform the standard IL-2-manufactured CAR-T.